Connect Biopharma Holdings Limited
CNTB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $76 | $65 | $48 | $269 |
| - Cash | $78 | $106 | $80 | $268 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$2 | -$40 | -$32 | $1 |
| Revenue | $26 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $26 | -$1 | -$1 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$22 | -$58 | -$117 | -$202 |
| % Margin | -83.7% | – | – | – |
| Net Income | -$16 | -$60 | -$116 | -$205 |
| % Margin | -60% | – | – | – |
| EPS Diluted | -0.28 | -1.08 | -14.5 | -25 |
| % Growth | 74.1% | 92.6% | 42% | – |
| Operating Cash Flow | -$24 | -$48 | -$99 | -$86 |
| Capital Expenditures | -$1 | -$0 | -$4 | -$7 |
| Free Cash Flow | -$24 | -$48 | -$104 | -$93 |